A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy | Journal of the American Chemical Society
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Annual Report 2019
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
Models of WDR5-mediated histone H3K4 trimethylation, gene... | Download Scientific Diagram
Follow Daniel Schultz's (@thedatatinkerer) latest Tweets / Twitter
4E (@4E11193) / Twitter
Annual Report 2019
World Journal of Stem Cells
WIN site inhibition disrupts a subset of WDR5 function | Scientific Reports
Annual Report 2019
Frontiers | MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion
World Journal of Stem Cells
WIN site inhibition disrupts a subset of WDR5 function | Scientific Reports
teori uçurum Diğer bir deyişle hırsız yapacağım külhanbeyi florian aigner transfermarkt - smudla.net
Follow Daniel Schultz's (@thedatatinkerer) latest Tweets / Twitter
Foreign Rights List Frankfurt Book Fair 2012 - Matthes & Seitz
WIN site inhibition disrupts a subset of WDR5 function | Scientific Reports
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization | Journal of Medicinal Chemistry
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia | Nature Chemical Biology
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective | Journal of Medicinal Chemistry
Annual Report 2019
MLL/WDR5 protein-protein interaction inhibitors block MLL and WDR5... | Download Scientific Diagram
Impact of WIN site inhibitor on the WDR5 interactome. - Abstract - Europe PMC
